The purpose of this grant opportunity is to support patients from two population groups who face extra costs associated with fertility preservation:people who require fertility treatment, including

fertility preservation, due to a cancer diagnosis, and people at risk of passing on genetic conditions who have undergone pre-implantation genetic testing funded by the Medicare Benefit Schedule (MBS), as described in MBS items 13207, 73384, 73385, 73386 or 73387.  Costs associated with the cryostorage of eggs, sperm or embryos are not currently subsidised through the Medical Benefits Schedule…